Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNS Marinus Pharmaceuticals

停牌 02-10 16:00:00 EST

0.5500

+0.0000

0.00%

最高0.5500	最低0.5500	成交量0.00
今开0.5500	昨收0.5500	日振幅0.00%
总市值3,035万	流通市值1,898万	总股本5,519万
成交额60.56万	换手率0.00%	流通股本3,452万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":0.55,"timestamp":1739221200000,"preClose":0.55,"halted":3,"volume":0,"delay":0,"floatShares":34515218,"shares":55185622,"eps":-2.466183,"marketStatus":"停牌","change":0,"latestTime":"02-10 16:00:00 EST","open":0.55,"high":0.55,"low":0.55,"amount":605612.7769515,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.466183,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1406779200000,"exchange":"NASDAQ","adjPreClose":0.55,"volumeRatio":0},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2495105528","title":"Marinus Pharmaceuticals, Inc.股价拉升38.58% 市值涨1178.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495105528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495105528?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:32","pubTimestamp":1735569178,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时32分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅拉升38.58%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。消息层面，截至22时32分，《全球罕见病公司Immedica拟现金收购Marinus Pharmaceuticals》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。该信息摘要如下：全球罕见病公司Immedica Pharma将通过收购要约和随后合并收购Marinus Pharmaceuticals 此次收购补充并进一步加强了Immedica的全球罕见病业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022325895f2c2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022325895f2c2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2495549440","title":"全球罕见病公司Immedica拟现金收购Marinus Pharmaceuticals(MRNS.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2495549440","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495549440?lang=zh_cn&edition=full","pubTime":"2024-12-30 20:46","pubTimestamp":1735562768,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，全球罕见病公司Immedica Pharma将通过收购要约和随后合并收购Marinus Pharmaceuticals (MRNS.US)。此次收购补充并进一步加强了Immedica的全球罕见病业务。截至发稿，Marinus 股价周一盘前大涨43.78%。Immedica将通过全资子公司发起收购要约，以每股0.55美元的现金收购Marinus的所有股份，按Marinus12月27日的收盘价计算，溢价为48%。该交易预计将于2025年第一季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1231207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"全球罕见病公司Immedica拟现金收购Marinus Pharmaceuticals(MRNS.US)","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2494781866","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494781866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494781866?lang=zh_cn&edition=full","pubTime":"2024-12-26 22:51","pubTimestamp":1735224693,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日22时51分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅上涨6.07%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Scisparc Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings, Inc.涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为1506.83%、287.60%、104.93%，振幅较大的相关个股有Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Molecular Templates, Inc.，振幅分别为144.94%、68.73%、54.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226225133ab93914e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226225133ab93914e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2494402031","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494402031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494402031?lang=zh_cn&edition=full","pubTime":"2024-12-25 00:59","pubTimestamp":1735059594,"startTime":"0","endTime":"0","summary":"北京时间2024年12月25日00时59分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.55%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，180 Life Sciences Corp.、Revelation Biosciences Inc C/Wts 10/01/2027 、Clearmind Medicine Inc.涨幅较大，Clearmind Medicine Inc.、180 Life Sciences Corp.、Theriva Biologics, Inc.较为活跃，换手率分别为1142.02%、738.80%、226.12%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为73.16%、68.75%、56.68%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225005954a207e06f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225005954a207e06f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2493184897","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速拉升5.65%报0.243美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493184897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493184897?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:48","pubTimestamp":1734986921,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日04时48分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.65%。截至发稿，该股报0.243美元/股，成交量96.2649万股，换手率1.74%，振幅7.96%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Sol-Gel Technologies Ltd.、Traws Pharma, Inc.、Rapt Therapeutics, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Traws Pharma, Inc.、Gt Biopharma, Inc.较为活跃，换手率分别为1032.51%、923.70%、919.43%，振幅较大的相关个股有Sol-Gel Technologies Ltd.、Traws Pharma, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为245.92%、157.37%、148.33%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224044841ab8edde6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224044841ab8edde6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2491697860","title":"Marinus Pharmaceuticals, Inc.股价重挫10.12% 市值跌63.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697860?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:44","pubTimestamp":1734360279,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时44分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫10.12%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为38.99%、32.73%、30.20%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224439ab7c9ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224439ab7c9ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2491617374","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅跳水5.03%报0.259美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491617374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491617374?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:36","pubTimestamp":1734104201,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时36分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.03%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Cardiff Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为56.16%、50.09%、33.09%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为43.30%、43.12%、39.33%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233641984bd9c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233641984bd9c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2490438075","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速跳水6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490438075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490438075?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:59","pubTimestamp":1734015579,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时59分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.69%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2984.20%、723.75%、64.78%，振幅较大的相关个股有Palisade Bio, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aptevo Therapeutics Inc.，振幅分别为56.43%、55.45%、37.26%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121222593995e93819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121222593995e93819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2490127600","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490127600","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490127600?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:18","pubTimestamp":1733843890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时18分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.19%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1902.13%、436.00%、110.00%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd.，振幅分别为150.29%、131.78%、38.65%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023181195e8b0c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023181195e8b0c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2489319258","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.24%报0.295美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489319258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489319258?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:19","pubTimestamp":1733501963,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时19分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.24%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029、Adc Therapeutics Sa涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为125.23%、71.85%、57.68%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cervomed Inc.、Adc Therapeutics Sa，振幅分别为190.28%、41.15%、40.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001924a1d9a467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001924a1d9a467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2489463081","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.45%报0.288美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489463081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489463081?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:16","pubTimestamp":1733411799,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时16分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.45%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2192.88%、765.41%、352.70%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为109.61%、92.09%、84.26%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523163998e5a07b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523163998e5a07b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2488492019","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488492019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488492019?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:49","pubTimestamp":1733237384,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时49分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.47%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为133.65%、84.04%、76.49%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、37.96%、28.70%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322494498e51cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322494498e51cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2486337630","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486337630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486337630?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:54","pubTimestamp":1732546476,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时54分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.69%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为93.97%、85.21%、51.22%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Citius Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为61.31%、36.25%、34.34%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225436abde05e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225436abde05e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2485428473","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485428473?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:57","pubTimestamp":1732222652,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时57分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.02%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Briacell Therapeutics Corp.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为995.69%、552.22%、417.91%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Biodexa Pharmaceuticals Plc，振幅分别为162.20%、87.47%、84.16%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112204573298e44000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112204573298e44000&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2484067073","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.00%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484067073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484067073?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:59","pubTimestamp":1731945564,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时59分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报0.320美元/股，成交量39.3001万股，换手率0.71%，振幅6.26%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2483864048","title":"Marinus Pharmaceuticals, Inc.2024财年第三财季实现净利润-24.23百万美元，同比增加26.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483864048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483864048?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:00","pubTimestamp":1731542419,"startTime":"0","endTime":"0","summary":"11月14日，Marinus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-24.23百万美元，同比增加26.51%；其中营业收入为8.54百万美元，同比增加16.35%，每股基本收益为-0.42美元。机构评级：截至2024年11月14日，当前有6家机构对Marinus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为1.83美元，其中最低目标价为0.50美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS"],"gpt_icon":0},{"id":"2483243881","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌8.38%报0.316美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483243881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483243881?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅跳水8.38%。截至发稿，该股报0.316美元/股，成交量6.9605万股，换手率0.13%，振幅2.15%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.62%、174.16%、84.72%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、10.27%、9.75%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2481101713","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101713?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:43","pubTimestamp":1731076995,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时43分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.60%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Matinas Biopharma Holdings, Inc.、Fortrea Holdings Inc.、Inhibikase Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为449.83%、30.24%、18.84%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Matinas Biopharma Holdings, Inc.，振幅分别为86.00%、31.72%、23.50%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2481493709","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481493709?lang=zh_cn&edition=full","pubTime":"2024-11-07 03:20","pubTimestamp":1730920835,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日03时20分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.62%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为3373.67%、505.53%、152.44%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为128.03%、82.72%、59.87%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2480058584","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速下挫5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:56","pubTimestamp":1730732185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.28%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为256.46%、210.05%、56.09%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0009},{"period":"6month","weight":0.5924},{"period":"1year","weight":-0.6029},{"period":"ytd","weight":0.0278}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司，致力于开发用于治疗癫痫疾病的创新疗法，包括罕见的遗传性癫痫和癫痫持续状态，其中包括使用ZTALMY（加奈索酮）。该公司正在开发用于两种不同给药途径的制剂中的加奈索酮：静脉注射（IV）和口服。不同的配方旨在最大限度地提高加奈索酮在成人和儿科患者群体中的潜在治疗应用，包括急性和慢性护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.035646},{"month":2,"riseRate":0.636364,"avgChangeRate":-0.009694},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007141},{"month":6,"riseRate":0.5,"avgChangeRate":0.034813},{"month":7,"riseRate":0.6,"avgChangeRate":0.022118},{"month":8,"riseRate":0.454545,"avgChangeRate":0.029644},{"month":9,"riseRate":0.636364,"avgChangeRate":0.195949},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.205727},{"month":11,"riseRate":0.454545,"avgChangeRate":0.029632},{"month":12,"riseRate":0.636364,"avgChangeRate":0.171191}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}